a multidisciplinary group of scientists, clinicians, and investors with deep experience in advanced biologics and translational therapies. Collectively, the team has contributed to peer-reviewed scientific publications, participated in clinical research and trials, and helped advance biologic platforms from early research through clinical application. This combination of scientific rigor, real-world clinical insight, and long-term investment perspective allows PranaGen to operate with discipline, credibility, and a focus on responsible innovation.